Literature DB >> 26170154

A microfluidic platform with digital readout and ultra-low detection limit for quantitative point-of-care diagnostics.

Ying Li1, Jie Xuan, Yujun Song, Ping Wang, Lidong Qin.   

Abstract

Quantitative assays are of great importance for point-of-care (POC) diagnostics because they can offer accurate information on the analytes. However, current POC devices often require an accessory instrument to give quantitative readouts for protein biomarkers, especially for those at very low concentration levels. Here, we report a microfluidic platform, the digital volumetric bar-chart chip (DV-chip), for quantitative POC diagnostics with ultra-low detection limits that are readable with the naked eye. Requiring no calibration, the DV-chip presents a digital ink bar chart (representing multiple bits composed of 0 and 1) for the target biomarker based on direct competition between O2 generated by the experimental and control samples. The bar chart clearly and accurately defines target concentration, allowing identification of disease status. For the standard PtNP solutions, the detection limit of the platform is approximately 0.1 pM and the dynamic range covers four orders of magnitude from 0.1 to 1000 pM. CEA samples with concentrations of 1 ng mL(-1) and 1.5 ng mL(-1) could be differentiated by the device. We also performed the ELISA assay for B-type natriuretic peptide (BNP) in 20 plasma samples from heart failure patients and the obtained on-chip data were in agreement with the clinical results. In addition, BNP was detectable at concentrations of less than 5 pM, which is three orders of magnitude lower than the detection limit of the previously reported readerless digital methods. By the integration of gas competition, volumetric bar chart, and digital readout, the DV-chip possesses merits of portability, visible readout, and ultra-low detection limit, which should offer a powerful platform for quantitative POC diagnostics in clinical settings and personalized detection.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26170154      PMCID: PMC4561225          DOI: 10.1039/c5lc00529a

Source DB:  PubMed          Journal:  Lab Chip        ISSN: 1473-0189            Impact factor:   6.799


  36 in total

1.  Multiplexed detection of protein cancer markers with biobarcoded nanoparticle probes.

Authors:  Savka I Stoeva; Jae-Seung Lee; Jennifer E Smith; Steven T Rosen; Chad A Mirkin
Journal:  J Am Chem Soc       Date:  2006-07-05       Impact factor: 15.419

2.  Digital microfluidic assay for protein detection.

Authors:  Janine Mok; Michael N Mindrinos; Ronald W Davis; Mehdi Javanmard
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-21       Impact factor: 11.205

3.  A paper-based multiplexed transaminase test for low-cost, point-of-care liver function testing.

Authors:  Nira R Pollock; Jason P Rolland; Shailendra Kumar; Patrick D Beattie; Sidhartha Jain; Farzad Noubary; Vicki L Wong; Rebecca A Pohlmann; Una S Ryan; George M Whitesides
Journal:  Sci Transl Med       Date:  2012-09-19       Impact factor: 17.956

4.  Significance of CEA and CA19-9 combination as a prognostic indicator and for recurrence monitoring in patients with stage II colorectal cancer.

Authors:  Masatsune Shibutani; Kiyoshi Maeda; Hisashi Nagahara; Hiroshi Ohtani; Katsunobu Sakurai; Takahiro Toyokawa; Naoshi Kubo; Hiroaki Tanaka; Kazuya Muguruma; Masaichi Ohira; Kosei Hirakawa
Journal:  Anticancer Res       Date:  2014-07       Impact factor: 2.480

Review 5.  Biomarkers in acute heart failure--state of the art.

Authors:  Alan S Maisel; Rajiv Choudhary
Journal:  Nat Rev Cardiol       Date:  2012-05-01       Impact factor: 32.419

Review 6.  Are serial BNP measurements useful in heart failure management? Serial natriuretic peptide measurements are useful in heart failure management.

Authors:  James L Januzzi; Richard Troughton
Journal:  Circulation       Date:  2013-01-29       Impact factor: 29.690

7.  A plasmonic chip for biomarker discovery and diagnosis of type 1 diabetes.

Authors:  Bo Zhang; Rajiv B Kumar; Hongjie Dai; Brian J Feldman
Journal:  Nat Med       Date:  2014-07-13       Impact factor: 53.440

8.  B-type natriuretic peptide for diagnosis of heart failure in emergency department patients: a critical appraisal.

Authors:  Eric Schwam
Journal:  Acad Emerg Med       Date:  2004-06       Impact factor: 3.451

Review 9.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).

Authors:  Kenneth Dickstein; Alain Cohen-Solal; Gerasimos Filippatos; John J V McMurray; Piotr Ponikowski; Philip Alexander Poole-Wilson; Anna Strömberg; Dirk J van Veldhuisen; Dan Atar; Arno W Hoes; Andre Keren; Alexandre Mebazaa; Markku Nieminen; Silvia Giuliana Priori; Karl Swedberg
Journal:  Eur Heart J       Date:  2008-09-17       Impact factor: 29.983

10.  A list of candidate cancer biomarkers for targeted proteomics.

Authors:  Malu Polanski; N Leigh Anderson
Journal:  Biomark Insights       Date:  2007-02-07
View more
  6 in total

1.  Lateral flow assay ruler for quantitative and rapid point-of-care testing.

Authors:  Zhao Li; Hui Chen; Ping Wang
Journal:  Analyst       Date:  2019-04-10       Impact factor: 4.616

2.  Fast, Sensitive, and Quantitative Point-of-Care Platform for the Assessment of Drugs of Abuse in Urine, Serum, and Whole Blood.

Authors:  Ying Li; Uvaraj Uddayasankar; Bangshun He; Ping Wang; Lidong Qin
Journal:  Anal Chem       Date:  2017-07-26       Impact factor: 6.986

3.  Remotely tunable microfluidic platform driven by nanomaterial-mediated on-demand photothermal pumping.

Authors:  Guanglei Fu; Wan Zhou; XiuJun Li
Journal:  Lab Chip       Date:  2020-06-16       Impact factor: 6.799

4.  Nanoporous Glass Integrated in Volumetric Bar-Chart Chip for Point-of-Care Diagnostics of Non-Small Cell Lung Cancer.

Authors:  Ying Li; Jie Xuan; Yujun Song; Wenjin Qi; Bangshun He; Ping Wang; Lidong Qin
Journal:  ACS Nano       Date:  2015-12-28       Impact factor: 15.881

Review 5.  Recent Progress of Microfluidics in Translational Applications.

Authors:  Zongbin Liu; Xin Han; Lidong Qin
Journal:  Adv Healthc Mater       Date:  2016-03-22       Impact factor: 9.933

Review 6.  Point-of-Care Diagnostics: Recent Developments in a Connected Age.

Authors:  Samiksha Nayak; Nicole R Blumenfeld; Tassaneewan Laksanasopin; Samuel K Sia
Journal:  Anal Chem       Date:  2016-12-13       Impact factor: 6.986

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.